Literature DB >> 18076949

Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.

Darren E Whittemore1, Eric J Hick, Mark R Carter, Judd W Moul, Alejandro J Miranda-Sousa, Wade J Sexton.   

Abstract

PURPOSE: The Gleason grading system in reporting prostate cancer accounts for the primary and secondary Gleason pattern. The clinical significance of a higher tertiary (third most prevalent) grade is largely unrecognized.
MATERIALS AND METHODS: Radical prostatectomy specimens from 300 patients with Gleason score 7 (3 + 4 or 4 + 3) prostate cancer were pathologically reexamined for the presence of a tertiary grade 5 pattern as well as the association with pathological stage and biochemical recurrence-free survival.
RESULTS: A total of 214 patients met study inclusion criteria. Patients with Gleason score 7 and tertiary grade 5 cancer had significantly higher pathological stage disease than patients with Gleason score 7 without tertiary grade 5 cancer (p <0.001). Gleason score 7 + tertiary pattern 5 tumors were significantly associated with adverse pathological features such as seminal vesicle invasion, extraprostatic extension and lymphovascular invasion compared to Gleason score 7 tumors (p <0.05). The relative effects of a tertiary grade 5 component on all pathological parameters analyzed was greater for Gleason score 7 tumors with a lower primary Gleason pattern 3 vs a higher primary Gleason pattern 4. Patients with Gleason score 7 + tertiary pattern 5 tumors had significantly decreased biochemical recurrence-free survival (54 months) compared to patients with Gleason score 7 tumors (121 months) (p = 0.0005). Preoperative prostate specific antigen, lymphovascular invasion and positive surgical margin status were shown to be independent predictors of prostate specific antigen recurrence on multivariate analysis.
CONCLUSIONS: Small percentages of tertiary grade 5 patterns in Gleason score 7 radical prostatectomy specimens are associated with aggressive pathological features predictive of advanced pathological stage and biochemical recurrence-free survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18076949     DOI: 10.1016/j.juro.2007.09.085

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  19 in total

1.  Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?

Authors:  Hillary M Ross; Oleksandr N Kryvenko; Janet E Cowan; Jeffry P Simko; Thomas M Wheeler; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-09       Impact factor: 6.394

2.  Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer.

Authors:  Sean P Stroup; Daniel M Moreira; Zinan Chen; Lauren Howard; Jonathan H Berger; Martha K Terris; William J Aronson; Matthew R Cooperberg; Christopher L Amling; Christopher J Kane; Stephen J Freedland
Journal:  J Urol       Date:  2017-07-11       Impact factor: 7.450

3.  Prostate cancer: Effects of tertiary Gleason pattern 5 on oncological outcome.

Authors:  Sean R Williamson; Liang Cheng
Journal:  Nat Rev Urol       Date:  2015-01-20       Impact factor: 14.432

4.  The effect of Rapid Access Prostate Clinics on the outcomes of Gleason 7 prostate cancer: does earlier diagnosis lead to better outcomes?

Authors:  M P Broe; J C Forde; M S Inder; D J Galvin; D W Mulvin; D M Quinlan
Journal:  Ir J Med Sci       Date:  2017-03-09       Impact factor: 1.568

5.  Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study.

Authors:  Paulo Rodrigues; Flavio O Hering; Alex Meller
Journal:  Cancer Res Treat       Date:  2011-12-27       Impact factor: 4.679

6.  Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.

Authors:  Charlotte F Kweldam; Mark F Wildhagen; Ewout W Steyerberg; Chris H Bangma; Theodorus H van der Kwast; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

Review 7.  Grading of Prostate Cancer: Past, Present, and Future.

Authors:  Andres Matoso; Jonathan I Epstein
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

8.  Effect of Gleason scores of lymph node metastases on prognosis of patients with prostate cancer.

Authors:  Kyungtae Ko; In Gab Jeong; Woo Suk Choi; Ju Hyun Lim; Ja Hee Suh; Ja Hyeon Ku; Yangsoon Park; Kyung Cheol Moon; Hyeon Hoe Kim; Choung-Soo Kim; Cheol Kwak
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 9.  Treatment strategies for high-risk locally advanced prostate cancer.

Authors:  Seth A Rosenthal; Howard M Sandler
Journal:  Nat Rev Urol       Date:  2010-01       Impact factor: 14.432

10.  Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.

Authors:  Bruce J Trock; Charles C Guo; Mark L Gonzalgo; Ahmed Magheli; Stacy Loeb; Jonathan I Epstein
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.